Atorvastatin Therapy on Xanthoma in Alagille Syndrome

Clinical trial NCT05488067 · COMPLETED

Trial details

NCT number: NCT05488067
Sponsor: Children's Hospital of Fudan University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alagille Syndrome Atorvastatin Xanthoma

Start date: 2022-03-22
Primary completion: 2024-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.